Skip to main content
Clinical Trials/NCT02469220
NCT02469220
Completed
Not Applicable

Diet Treatment of Patients With Ulcerative Colitis in Remission

Vendsyssel Hospital1 site in 1 country19 target enrollmentJuly 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ulcerative Colitis
Sponsor
Vendsyssel Hospital
Enrollment
19
Locations
1
Primary Endpoint
Gastrointestinal symptoms
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study examines the effect of a low FODMAP diet in patients with UC in remission but still having GI symptoms (IBS in IBD). 15 patients will be on watchful waiting. 15 patients will be on low FODMAP diet. 15 patients with recieve FODMAPs in their diet.

Detailed Description

Patients are randomized to either standard care, low FODMAP diet or a normal FODMAP diet. Run-in on a low FODMAP diet, thereafter parallel design where one arm is assign a blinded food supplement with low FODMAP content and the other arm is assigned a blinded food supplement containing FODMAP. A control group is "watchful waiting". Symptom reports, blood, and fecal samples are collected.

Registry
clinicaltrials.gov
Start Date
July 1, 2018
End Date
April 26, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Vendsyssel Hospital
Responsible Party
Principal Investigator
Principal Investigator

Anne Lund Krarup

MD, PhD

Vendsyssel Hospital

Eligibility Criteria

Inclusion Criteria

  • Colitis ulcerosa in remission (calciprotectin\<200 and normal sigmoidoscopy)
  • ROM IV criteria fullfilled
  • Stable medical therapy

Exclusion Criteria

  • Intake of a low FODMAP diet within the past 6 weeks prior to baseline
  • Atypical colitis ulcerosa primarily right sided disease and calciprotectin \>50 unless normal sigmoidoscopy
  • If diarrhea: Clostridium difficile infection
  • Lactose intolerance
  • Systemisk or local treatment for CU other than 5-aminosalicylicacid or biological therapy
  • Antibiotics within 6 weeks
  • Pregnancy
  • Activity in UC
  • Coeliac disease
  • Abnormal transglutaminase

Outcomes

Primary Outcomes

Gastrointestinal symptoms

Time Frame: Week 8

IBS-SSS questionnaire

Secondary Outcomes

  • Change in Quality of life(Week 8)
  • Pain diary(Daily during the study)

Study Sites (1)

Loading locations...

Similar Trials